E. Ohman J or Asset Management AB Lowers Stock Holdings in IQVIA Holdings Inc. (NYSE:IQV)

E. Ohman J or Asset Management AB decreased its position in shares of IQVIA Holdings Inc. (NYSE:IQV) by 3.1% during the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 7,461 shares of the medical research company’s stock after selling 240 shares during the quarter. E. Ohman J or Asset Management AB’s holdings in IQVIA were worth $1,768,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of the company. Investment Research & Advisory Group Inc. lifted its stake in shares of IQVIA by 1.9% during the 3rd quarter. Investment Research & Advisory Group Inc. now owns 17,843 shares of the medical research company’s stock valued at $4,228,000 after buying an additional 328 shares in the last quarter. IFM Investors Pty Ltd increased its holdings in IQVIA by 2.3% in the 3rd quarter. IFM Investors Pty Ltd now owns 37,176 shares of the medical research company’s stock valued at $8,810,000 after acquiring an additional 835 shares during the last quarter. Bogart Wealth LLC increased its holdings in IQVIA by 80.5% in the 3rd quarter. Bogart Wealth LLC now owns 36,566 shares of the medical research company’s stock valued at $8,665,000 after acquiring an additional 16,305 shares during the last quarter. CENTRAL TRUST Co increased its holdings in IQVIA by 35.0% in the 3rd quarter. CENTRAL TRUST Co now owns 690 shares of the medical research company’s stock valued at $163,000 after acquiring an additional 179 shares during the last quarter. Finally, Great Lakes Retirement Inc. increased its holdings in IQVIA by 6.3% in the 3rd quarter. Great Lakes Retirement Inc. now owns 2,876 shares of the medical research company’s stock valued at $682,000 after acquiring an additional 170 shares during the last quarter. Hedge funds and other institutional investors own 89.62% of the company’s stock.

IQVIA Price Performance

IQVIA stock opened at $214.63 on Friday. The stock has a market cap of $39.11 billion, a price-to-earnings ratio of 29.32, a price-to-earnings-growth ratio of 2.22 and a beta of 1.49. The company has a debt-to-equity ratio of 1.80, a current ratio of 0.85 and a quick ratio of 0.85. IQVIA Holdings Inc. has a 1 year low of $167.42 and a 1 year high of $261.73. The firm has a 50-day moving average of $238.13 and a two-hundred day moving average of $230.78.

Analyst Upgrades and Downgrades

IQV has been the topic of a number of research reports. StockNews.com downgraded shares of IQVIA from a “buy” rating to a “hold” rating in a report on Tuesday. Royal Bank of Canada started coverage on shares of IQVIA in a report on Wednesday, September 4th. They issued an “outperform” rating and a $275.00 price target on the stock. Evercore ISI reduced their target price on shares of IQVIA from $270.00 to $265.00 and set an “outperform” rating on the stock in a report on Tuesday, October 8th. Barclays reduced their target price on shares of IQVIA from $275.00 to $260.00 and set an “overweight” rating on the stock in a report on Tuesday, October 15th. Finally, Redburn Atlantic started coverage on shares of IQVIA in a report on Monday, October 14th. They issued a “buy” rating and a $276.00 target price on the stock. Five analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, IQVIA currently has a consensus rating of “Moderate Buy” and an average price target of $267.27.

Insider Transactions at IQVIA

In other news, insider Eric Sherbet sold 1,300 shares of the company’s stock in a transaction that occurred on Tuesday, August 27th. The shares were sold at an average price of $246.33, for a total value of $320,229.00. Following the completion of the sale, the insider now owns 19,536 shares of the company’s stock, valued at approximately $4,812,302.88. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 1.60% of the company’s stock.

IQVIA Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.